By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Selexis SA 

Chemin des Aulx, 14

Plan les Ouates   Geneva  1228   Switzerland
Phone: 41-0.-22-308-93-60 Fax:


SEARCH JOBS


Key Statistics


Email: info@selexis.com
Ownership: Private

Web Site: Selexis SA
Employees:
Symbol: 
 



Industry
Biotechnology

Segment
Start Up





Company News
Selexis SA Announces Launch Of Novel Cell Selection Platform Designed To Help Advance Difficult-To-Express Protein Therapeutics To The Clinic 3/20/2017 6:35:23 AM
Selexis SA Announces Participation At Several Upcoming Industry Conferences 3/14/2017 8:28:50 AM
Selexis SA Inks Agreement For Applications In Cancer And Infectious Disease 2/21/2017 8:30:25 AM
Selexis SA And OSE Immunotherapeutics Collaborate To Advance Development Of Immunotherapies For Cancer And Autoimmune Diseases 11/16/2016 10:36:03 AM
Selexis SA And OSE Immunotherapeutics Collaborate To Advance Development Of Immunotherapies For Cancer And Autoimmune Diseases 11/15/2016 11:29:07 AM
Selexis SA And Xencor Enter Strategic Agreement, Strengthening Existing Relationship For Multi-Specific Antibody Cell Line Development 11/3/2016 11:29:22 AM
Selexis SA And Xencor Enter Strategic Agreement, Strengthening Existing Relationship For Multi-Specific Antibody Cell Line Development 11/3/2016 9:02:10 AM
Selexis SA Inks Commercial Cell Line License Agreement With Immunext For Anti-CD40L Antibody Being Developed For Treatment Of Chronic Autoimmune Disorders 10/25/2016 10:09:30 AM
Selexis SA Release: Protein Expression Challenges? Meet Us At PEGS-Europe And BIO-Europe 10/10/2016 11:25:11 AM
Selexis SA Announces Participation At Two Upcoming Industry Conferences 10/10/2016 9:16:34 AM
123456
//-->